Sign in
Taking peopleNo phase

Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

Key facts

Who runs it
Shanghai Eye Disease Prevention and Treatment Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
108 people, planned
Started
9 Dec 2024
Planned end
9 Jun 2025
Type of study
Interventional, 9 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Repeated Low-level Red-light
  • Red LED
Record updated
4 December 2024

Who can take part

Age
8 years to 10 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Age: 8-10 years old
  • Low myopia: cycloplegic spherical equivalent refractions (SERs) range from -0.50 (inclusive) to -3.00 diopters (D) and astigmatism less than -2.5 D in either eye
  • signed informed consent and was able to participate in the study

Who cannot take part

  • Cloudy refractive media: cloudy cornea, cataract or intraocular lens surgery
  • Use of orthokeratology, atropine, multifocal frame glasses and other myopia control methods; children who are currently receiving atropine, orthokeratology, multifocal frame glasses and other myopia control treatment, can be enrolled after 2 weeks of treatment
  • Secondary myopia, such as a history of retinopathy of prematurity or other neonatal diseases; syndromic myopia with a known genetic disorder or connective tissue disease, such as Stickler syndrome or Marfan syndrome
  • Eye diseases that affect retinal function: macular degeneration, diabetic retinopathy, retinal detachment, glaucoma or ocular hypertension, endophthalmitis, uveitis, optic neuropathy, etc
  • History of refractive surgery, internal eye surgery, laser therapy, vitreous injection, etc
  • diabetes, hypertension and other systemic disorders
  • History of use of retinal toxic drugs, such as hydroxychloroquine, etc
  • Other reasons considered unsuitable for inclusion by the study physician, including but not limited to other ocular and systemic disease abnormalities
  • Strabismus or other binocular vision abnormalities

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Myopia or choroidal thickness or retina

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To explore the minimum power and frequency of Repeated Low-level Red-light (RLRL) to control myopia progression in low-myopic children aged 8-10 years, and the rebound effect of low-myopic children after discontinuation of RLRL with different combinations of power and frequency.

The 9 groups in the trial

  • Red light: 2.0 mW/twice dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red light: 2.0 mW/once dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red light: 1.0 mW/twice dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red light: 1.0 mW/once dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red light: 0.5 mW/twice dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red light: 0.5 mW/once dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red light: 0.3 mW/twice dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red light: 0.3 mW/once dailyTreatment being tested

    Treatment: Repeated Low-level Red-light

  • Red LED: twice dailySham treatment, for comparison

    Treatment: Red LED

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
An Exploratory Study on the Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
Criteria questions
Built from NCT06717048, who can take part
Record updated
4 December 2024